Cargando…

Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic Mice

The antidiabetic potential of glucagon receptor antagonism presents an opportunity for use in an insulin-centric clinical environment. To investigate the metabolic effects of glucagon receptor antagonism in type 2 diabetes, we treated Lepr(db/db) and Lep(ob/ob) mice with REMD 2.59, a human monoclona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Ankit X., Quittner-Strom, Ezekiel B., Lee, Young, Johnson, Joshua A., Martin, Sarah A., Yu, Xinxin, Li, Jianping, Lu, John, Cai, Zheqing, Chen, Shiuhwei, Wang, May-yun, Zhang, Yiyi, Pearson, Mackenzie J., Dorn, Andie C., McDonald, Jeffrey G., Gordillo, Ruth, Yan, Hai, Thai, Dung, Wang, Zhao V., Unger, Roger H., Holland, William L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978750/ https://www.ncbi.nlm.nih.gov/pubmed/29444429 http://dx.doi.org/10.1016/j.celrep.2018.01.065

Ejemplares similares

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis
por: Holland, William L., et al.
Publicado: (2017)

Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists
por: Pearson, Mackenzie J., et al.
Publicado: (2016)

Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets
por: Wang, May-Yun, et al.
Publicado: (2021)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
por: Johanns, M., et al.
Publicado: (2016)

Role of cAMP in Double Switch of Glucagon Secretion
por: Zmazek, Jan, et al.
Publicado: (2021)

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
por: Wei, Tianjiao, et al.
Publicado: (2023)

Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor
por: Hennen, Stephanie, et al.
Publicado: (2016)

Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
por: Lafferty, Ryan A, et al.
Publicado: (2022)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP
por: Miller, Russell A., et al.
Publicado: (2013)

Nonclassical antagonism between human lysozyme and AMPs against Pseudomonas aeruginosa
por: Blumenthal, Ian, et al.
Publicado: (2021)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
por: Karimian, Negar, et al.
Publicado: (2013)

Glucose controls glucagon secretion by directly modulating cAMP in alpha cells
por: Yu, Qian, et al.
Publicado: (2019)

Glucagon, cyclic AMP, and hepatic glucose mobilization: A half‐century of uncertainty
por: Rodgers, Robert L.
Publicado: (2022)

Histone acetyltransferase inhibitors antagonize AMP-activated protein kinase in postmortem glycolysis
por: Li, Qiong, et al.
Publicado: (2017)

ATP Antagonizes Thrombin-Induced Signal Transduction through 12(S)-HETE and cAMP
por: Burzaco, Jaione, et al.
Publicado: (2013)

Angiopoietin-like protein 4 is an exercise-induced hepatokine in humans, regulated by glucagon and cAMP
por: Ingerslev, Bodil, et al.
Publicado: (2017)

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells
por: Elmelund, Emilie, et al.
Publicado: (2022)

Role of Fibroblast Growth Factor 21 in Biology of Glucagon
por: Berglund, Eric D., et al.
Publicado: (2013)

De novo adipocyte differentiation from Pdgfrβ(+) preadipocytes protects against pathologic visceral adipose expansion in obesity
por: Shao, Mengle, et al.
Publicado: (2018)

Leucine suppresses glucagon secretion from pancreatic islets by directly modulating α-cell cAMP
por: Knuth, Emily R., et al.
Publicado: (2023)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
por: Yue, Jessica T.Y., et al.
Publicado: (2012)

Glucagon changes substrate preference in gluconeogenesis
por: Xu, Huiting, et al.
Publicado: (2022)

Glutamine Triggers and Potentiates Glucagon-Like Peptide-1 Secretion by Raising Cytosolic Ca(2+) and cAMP
por: Tolhurst, Gwen, et al.
Publicado: (2011)

Glucagon‐like peptide‐1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats
por: Scalzo, Rebecca L., et al.
Publicado: (2018)

Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence
por: Baroni, Maurizio D., et al.
Publicado: (2018)

Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction
por: Karwi, Qutuba G., et al.
Publicado: (2019)

Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice
por: Wei, Rui, et al.
Publicado: (2019)

Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors
por: Jones, Ben, et al.
Publicado: (2020)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
por: Unger, Jeffrey R., et al.
Publicado: (2011)

Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis
por: Wang, Hai, et al.
Publicado: (2016)

Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment
por: Girada, Shravan Babu, et al.
Publicado: (2017)

Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
por: Shuai, Hongyan, et al.
Publicado: (2021)

Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
por: Guo, Wanjun, et al.
Publicado: (2023)

Top quark physics with ATLAS &amp;amp;amp;amp; CMS
por: Onofre, A
Publicado: (2009)

Cacao liquor procyanidins prevent postprandial hyperglycaemia by increasing glucagon-like peptide-1 activity and AMP-activated protein kinase in mice
por: Yamashita, Yoko, et al.
Publicado: (2019)

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
por: Lee, Young, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qo83cth2ic6si40mp9nlflb4o9